Stock 1BSL01AE BIOTIKA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biotika

Equities

1BSL01AE

CS0009013453

Pharmaceuticals

End-of-day quote Bratislava S.E.
Other stock markets
 06:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
23 EUR 0.00% Intraday chart for Biotika 0.00% +5.50%
Apr. 25 Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Biotika a.s. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2018 2020 2021 2022 2023
Capitalization 1 29.5 30.27 39.33 22.61 21.43
Enterprise Value (EV) 1 28.08 25.29 37.18 20.47 18.35
P/E ratio 18.6 x - 69 x -19.6 x 41.3 x
Yield 5.83% 8.39% 1.25% - -
Capitalization / Revenue 0.99 x 1.71 x 4.42 x 2.05 x 1.32 x
EV / Revenue 0.94 x 1.43 x 4.17 x 1.86 x 1.13 x
EV / EBITDA 9.47 x 5.91 x 17.7 x 87.4 x 12.5 x
EV / FCF 6.05 x 11.2 x 210 x 52.8 x 24.3 x
FCF Yield 16.5% 8.93% 0.48% 1.89% 4.12%
Price to Book 0.74 x - 1.05 x 0.63 x 0.58 x
Nbr of stocks (in thousands) 983 983 983 983 983
Reference price 2 30.00 31.00 40.00 23.00 21.80
Announcement Date 4/24/19 4/29/22 4/29/22 4/28/23 4/25/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2020 2021 2022 2023
Net sales 1 29.89 17.65 8.908 11.03 16.18
EBITDA 1 2.964 4.279 2.104 0.2342 1.469
EBIT 1 0.8334 2.158 0.4716 -1.078 0.1626
Operating Margin 2.79% 12.23% 5.29% -9.78% 1%
Earnings before Tax (EBT) 1 1.475 2.728 0.5147 -0.8428 0.2214
Net income 1 1.128 2.276 0.4057 -0.8198 0.3691
Net margin 3.77% 12.9% 4.55% -7.43% 2.28%
EPS 2 1.611 - 0.5796 -1.171 0.5273
Free Cash Flow 1 4.639 2.258 0.1771 0.3878 0.7564
FCF margin 15.52% 12.79% 1.99% 3.52% 4.67%
FCF Conversion (EBITDA) 156.51% 52.77% 8.42% 165.59% 51.47%
FCF Conversion (Net income) 411.35% 99.21% 43.65% - 204.93%
Dividend per Share 2 1.750 2.600 0.5000 - -
Announcement Date 4/24/19 4/29/22 4/29/22 4/28/23 4/25/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 1.41 4.97 2.15 2.14 3.09
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 4.64 2.26 0.18 0.39 0.76
ROE (net income / shareholders' equity) 3.88% 8.06% 1.48% -3.14% 1.43%
ROA (Net income/ Total Assets) 1.36% 4.1% 0.95% -2.29% 0.35%
Assets 1 83.19 55.46 42.62 35.79 106.8
Book Value Per Share 2 40.80 - 38.30 36.30 37.60
Cash Flow per Share 2 5.880 - 3.300 3.060 4.410
Capex 1 0.47 1.47 0.25 0.7 1.09
Capex / Sales 1.56% 8.31% 2.82% 6.38% 6.74%
Announcement Date 4/24/19 4/29/22 4/29/22 4/28/23 4/25/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
BIOTIKA Stock Biotika
+5.50% 17.5M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.63% 44.11B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+23.03% 22.71B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.22% 15.15B
CIPLA LIMITED Stock Cipla Limited
+12.66% 13.56B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+60.18% 12.7B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.02% 6.84B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.92% 5.63B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1BSL01AE Stock
  4. Financials Biotika
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW